In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC).

Using a plaque reduction assay, treatment of human influenza A viruses with the fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC) showed strong in vitro anti-influenza activity against human influenza A viruses before viral adsorption, but not after viral adsorption, with 50% inhibitory concentration (IC50) values against A/PR/8/34 (H1N1) virus, A/Aichi/2/68 (H3N2) virus and A/Memphis/1/71 (H3N2) virus of 6.35+/-0.17, 2.84+/-1.98 and 0.53+/-0.10 microg/ml, respectively. The plum-juice concentrate exhibited hemagglutination activity toward guinea pig erythrocytes. Its hemagglutination activity was inhibited by the monosaccharide N-acetylneuraminic acid and a sialoglycoprotein (fetuin), but not by the other tested monosaccharides (mannose, galactose, glucose and N-acetylglucosamine), suggesting the presence of a lectin-like molecule(s) in the Japanese plum-juice concentrate. Our findings suggest that the fruit-juice concentrate of Japanese plum may prevent and reduce infection with human influenza A virus, possibly via inhibition of viral hemagglutinin attachment to host cell surfaces by its lectin-like activity.

[1]  R. Saito,et al.  High prevalence of amantadine‐resistance influenza a (H3N2) in six prefectures, Japan, in the 2005–2006 Season , 2007, Journal of medical virology.

[2]  I. Barr,et al.  Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. , 2007, Antiviral research.

[3]  Yasuo Suzuki,et al.  Suppression of the biosynthesis of cellular sphingolipids results in the inhibition of the maturation of influenza virus particles in MDCK cells. , 2006, Biological & pharmaceutical bulletin.

[4]  Takashi Suzuki,et al.  Edible bird's nest extract inhibits influenza virus infection , 2006, Antiviral Research.

[5]  C. Shin,et al.  Isolation and characterization of a new compound from Prunus mume fruit that inhibits cancer cells. , 2006, Journal of agricultural and food chemistry.

[6]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[7]  Yasuo Suzuki,et al.  Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. , 2005, Biological & pharmaceutical bulletin.

[8]  G. Whittaker,et al.  Influenza virus entry and infection require host cell N-linked glycoprotein , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Miyamoto,et al.  In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection. , 2004, Biological & pharmaceutical bulletin.

[10]  Huashi Guan,et al.  Synthesis of cluster mannosides via a Ugi four-component reaction and their inhibition against the binding of yeast mannan to concanavalin A. , 2004, Carbohydrate research.

[11]  Dae-Ok Kim,et al.  Antioxidant capacity of phenolic phytochemicals from various cultivars of plums , 2003 .

[12]  P. Hernández-Cruz,et al.  Lectins in fruits having gastrointestinal activity: their participation in the hemagglutinating property of Escherichia coli O157:H7. , 2001, Archives of medical research.

[13]  Fleming Dm.  Managing influenza: amantadine, rimantadine and beyond. , 2001 .

[14]  Takashi Suzuki,et al.  Inactivation of Human Type A and B Influenza Viruses by Tea-Seed Saponins , 2000, Bioscience, biotechnology, and biochemistry.

[15]  Wakamiya,et al.  Human mannan‐binding lectin inhibits the infection of influenza A virus without complement , 1999, Immunology.

[16]  M. Ohnishi-Kameyama,et al.  Mumefural, citric acid derivative improving blood fluidity from fruit-juice concentrate of Japanese apricot (Prunus mume Sieb. et Zucc). , 1999, Journal of agricultural and food chemistry.

[17]  D. Miyamoto,et al.  Thujaplicin-copper chelates inhibit replication of human influenza viruses. , 1998, Antiviral research.

[18]  Y. Kawaoka,et al.  Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. , 1996, The Biochemical journal.

[19]  Katsuhisa,et al.  Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. , 1986, The Journal of biological chemistry.

[20]  M. Matsumoto,et al.  N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. , 1985, The Journal of biological chemistry.

[21]  Portland Press Ltd.  Nomenclature Committee of IUB (NC-IUB) IUB-IUPAC Joint Commission on Biochemical Nomenclature (JCBN) Newsletter 1984 , 1984, The Journal of biological chemistry.

[22]  M. Potier,et al.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. , 1979, Analytical biochemistry.

[23]  M. Tatematsu,et al.  Inhibition of Helicobacter pylori motility by (+)-Syringaresinol from unripe Japanese apricot. , 2006, Biological & pharmaceutical bulletin.

[24]  G. Shui,et al.  An investigation of antioxidant capacity of fruits in Singapore markets , 2002 .

[25]  F. Hayden,et al.  Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. , 1992, Current topics in microbiology and immunology.